We apply human iPSC expertise and commercial cell manufacturing experience to cell therapy by designing and delivering iPSC solutions to your requirements. Offerings include basic research, proof of concept studies, process development and large-scale custom manufacturing of a range of cell types.

Ncardia develops and delivers state-of-the-art integrated cardiovascular services to enhance the assessment of cardiac safety and toxicity of drug candidates. Our services are based on fully functional and validated hiPSC-derived cell models that are manufactured under strict quality assurance.